Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Manipal Health EnterprisesNSE:MANIPALHOS -3.30%13 Debt-to-EBITDA is 4.54 as of Mar. 2026, which is at its 10-year median of 4.54. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 479 Healthcare Providers & Services companies, Manipal Health Enterprises ranks worse than 74.53% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Manipal Health Enterprises's Debt-to-EBITDA or its related term are showing as below:
NSE:MANIPALHOS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.32 Med: 4.54 Max: 4.85
Current: 4.54
During the past 3 years, the highest Debt-to-EBITDA Ratio of Manipal Health Enterprises was 4.85. The lowest was 3.32. And the median was 4.54.
NSE:MANIPALHOS's Debt-to-EBITDA is ranked worse than 74.53% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 2.19
vs NSE:MANIPALHOS: 4.54
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Manipal Health Enterprises Debt-to-EBITDA Related Terms
Manipal Health Enterprises Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Manipal Health Enterprises Debt-to-EBITDA Chart
Manipal Health Enterprises Annual Data
Trend
Mar24
Mar25
Mar26
Debt-to-EBITDA
3.32
4.85
4.54
Manipal Health Enterprises Semi-Annual Data
Mar24
Mar25
Mar26
Debt-to-EBITDA
3.32
4.85
4.54
NSE:MANIPALHOS vs : Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Manipal Health Enterprises's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Manipal Health Enterprises Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Manipal Health Enterprises's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Manipal Health Enterprises's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is one times the quarterly (Mar. 2026) EBITDA data.
Manipal Health Enterprises (NSE:MANIPALHOS) has a Debt-to-EBITDA of 4.54 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Manipal Health Enterprises. This is near median its historical median of 4.54. Over the past decade, Manipal Health Enterprises' Debt-to-EBITDA has ranged from 3.32 to 4.85. According to the industry distribution chart, Manipal Health Enterprises ranks #357 out of 479 companies in the Healthcare Providers & Services industry, placing it in the top 74.5%.
Is Manipal Health Enterprises' Debt-to-EBITDA too high?
Manipal Health Enterprises' current Debt-to-EBITDA of 4.54 is near median its 10-year median of 4.54. Over the past 10 years, this metric has ranged from a low of 3.32 to a high of 4.85. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Manipal Health Enterprises' value of 4.54 is 107.3% above this industry median. Based on the distribution chart, Manipal Health Enterprises ranks #357 out of 479 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' Debt-to-EBITDA compare to ?
According to the Healthcare Providers & Services industry distribution chart, Manipal Health Enterprises ranks #357 out of 479 companies for Debt-to-EBITDA. This places Manipal Health Enterprises in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Manipal Health Enterprises' value of 4.54 is 107.3% above this benchmark. Historically, Manipal Health Enterprises' own Debt-to-EBITDA has ranged from 3.32 to 4.85 over the past decade. While the company's 10-year median is 4.54 vs. the industry median of 2.19, Manipal Health Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Manipal Health Enterprises's current Debt-to-EBITDA of 4.54 is 107.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Manipal Health Enterprises. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Manipal Health Enterprises's current Debt-to-EBITDA is 4.54, which is near median its own 10-year median of 4.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current Debt-to-EBITDA of 4.54. The current Debt-to-EBITDA is 4.54, which is near median its 10-year median of 4.54 and 107.3% above the Healthcare Providers & Services industry median of 2.19. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current Debt-to-EBITDA is 4.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score
Get the complete analysis for NSE:MANIPALHOS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANIPALHOS has been successfully added to your 
